Correlates of hepatitis C virus infection in the targeted testing program of the New York city jail system

Epidemiologic patterns and priorities for action

Matthew J. Akiyama, Fatos Kaba, Zachary Rosner, Howard Alper, Aimee Kopolow, Alain H. Litwin, Homer Venters, Ross Macdonald

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: The objective of this study was to understand predictors of hepatitis C virus (HCV) antibody positivity in a large urban jail system in New York City. Methods: We examined demographic characteristics, risk behaviors, and HCV antibody prevalence among 10 790 jail inmates aged 16 to 86 who were screened from June 13, 2013, to June 13, 2014, based on birth cohort or conventional high-risk criteria. We used logistic regression analysis to determine predictors of HCV antibody positivity. Results: Of the 10 790 inmates screened, 2221 (20.6%) were HCV antibody positive. In the multivariate analysis, HCV antibody positivity was associated most strongly with injection drug use (IDU; adjusted odds ratio [aOR] = 35.0; 95% confidence interval [CI], 28.5-43.0). Women were more likely than men to be infected with HCV (aOR = 1.3; 95% CI, 1.1-1.5). Compared with non-Hispanic black people, Hispanic (aOR = 2.1; 95% CI, 1.8-2.4) and non-Hispanic white (aOR = 1.7; 95% CI, 1.5-2.1) people were more likely to be infected with HCV. Non-IDU, recidivism, HIV infection, homelessness, mental illness, and lower education level were all significantly associated with HCV infection. The prevalence rate of HCV infection among a subset of inmates born after 1965 who denied IDU and were not infected with HIV was 5.6% (198 of 3529). Predictors of HCV infection among this group included non-IDU as well as being non-Hispanic white, Hispanic, recidivist, and homeless. Conclusion: These data reveal differences in HCV infection by sex, race/ethnicity, and socioeconomics in a large jail population, suggesting that a focused public health intervention is required and that universal screening may be warranted. Further sensitivity and cost-benefit analyses are needed to make this determination.

Original languageEnglish (US)
Pages (from-to)41-47
Number of pages7
JournalPublic Health Reports
Volume132
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Virus Diseases
Hepatitis C Antibodies
Hepacivirus
Odds Ratio
Confidence Intervals
Hispanic Americans
Homeless Persons
Risk-Taking
HIV Infections
Cost-Benefit Analysis
Multivariate Analysis
Public Health
Logistic Models
Regression Analysis
Demography
HIV
Parturition
Education
Injections
Pharmaceutical Preparations

Keywords

  • Corrections
  • HCV
  • Jail

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Correlates of hepatitis C virus infection in the targeted testing program of the New York city jail system : Epidemiologic patterns and priorities for action. / Akiyama, Matthew J.; Kaba, Fatos; Rosner, Zachary; Alper, Howard; Kopolow, Aimee; Litwin, Alain H.; Venters, Homer; Macdonald, Ross.

In: Public Health Reports, Vol. 132, No. 1, 01.01.2017, p. 41-47.

Research output: Contribution to journalArticle

Akiyama, Matthew J. ; Kaba, Fatos ; Rosner, Zachary ; Alper, Howard ; Kopolow, Aimee ; Litwin, Alain H. ; Venters, Homer ; Macdonald, Ross. / Correlates of hepatitis C virus infection in the targeted testing program of the New York city jail system : Epidemiologic patterns and priorities for action. In: Public Health Reports. 2017 ; Vol. 132, No. 1. pp. 41-47.
@article{4f086c9329764e509787490da8cc8ab5,
title = "Correlates of hepatitis C virus infection in the targeted testing program of the New York city jail system: Epidemiologic patterns and priorities for action",
abstract = "Objective: The objective of this study was to understand predictors of hepatitis C virus (HCV) antibody positivity in a large urban jail system in New York City. Methods: We examined demographic characteristics, risk behaviors, and HCV antibody prevalence among 10 790 jail inmates aged 16 to 86 who were screened from June 13, 2013, to June 13, 2014, based on birth cohort or conventional high-risk criteria. We used logistic regression analysis to determine predictors of HCV antibody positivity. Results: Of the 10 790 inmates screened, 2221 (20.6{\%}) were HCV antibody positive. In the multivariate analysis, HCV antibody positivity was associated most strongly with injection drug use (IDU; adjusted odds ratio [aOR] = 35.0; 95{\%} confidence interval [CI], 28.5-43.0). Women were more likely than men to be infected with HCV (aOR = 1.3; 95{\%} CI, 1.1-1.5). Compared with non-Hispanic black people, Hispanic (aOR = 2.1; 95{\%} CI, 1.8-2.4) and non-Hispanic white (aOR = 1.7; 95{\%} CI, 1.5-2.1) people were more likely to be infected with HCV. Non-IDU, recidivism, HIV infection, homelessness, mental illness, and lower education level were all significantly associated with HCV infection. The prevalence rate of HCV infection among a subset of inmates born after 1965 who denied IDU and were not infected with HIV was 5.6{\%} (198 of 3529). Predictors of HCV infection among this group included non-IDU as well as being non-Hispanic white, Hispanic, recidivist, and homeless. Conclusion: These data reveal differences in HCV infection by sex, race/ethnicity, and socioeconomics in a large jail population, suggesting that a focused public health intervention is required and that universal screening may be warranted. Further sensitivity and cost-benefit analyses are needed to make this determination.",
keywords = "Corrections, HCV, Jail",
author = "Akiyama, {Matthew J.} and Fatos Kaba and Zachary Rosner and Howard Alper and Aimee Kopolow and Litwin, {Alain H.} and Homer Venters and Ross Macdonald",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/0033354916679367",
language = "English (US)",
volume = "132",
pages = "41--47",
journal = "Public Health Reports",
issn = "0033-3549",
publisher = "Association of Schools of Public Health",
number = "1",

}

TY - JOUR

T1 - Correlates of hepatitis C virus infection in the targeted testing program of the New York city jail system

T2 - Epidemiologic patterns and priorities for action

AU - Akiyama, Matthew J.

AU - Kaba, Fatos

AU - Rosner, Zachary

AU - Alper, Howard

AU - Kopolow, Aimee

AU - Litwin, Alain H.

AU - Venters, Homer

AU - Macdonald, Ross

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: The objective of this study was to understand predictors of hepatitis C virus (HCV) antibody positivity in a large urban jail system in New York City. Methods: We examined demographic characteristics, risk behaviors, and HCV antibody prevalence among 10 790 jail inmates aged 16 to 86 who were screened from June 13, 2013, to June 13, 2014, based on birth cohort or conventional high-risk criteria. We used logistic regression analysis to determine predictors of HCV antibody positivity. Results: Of the 10 790 inmates screened, 2221 (20.6%) were HCV antibody positive. In the multivariate analysis, HCV antibody positivity was associated most strongly with injection drug use (IDU; adjusted odds ratio [aOR] = 35.0; 95% confidence interval [CI], 28.5-43.0). Women were more likely than men to be infected with HCV (aOR = 1.3; 95% CI, 1.1-1.5). Compared with non-Hispanic black people, Hispanic (aOR = 2.1; 95% CI, 1.8-2.4) and non-Hispanic white (aOR = 1.7; 95% CI, 1.5-2.1) people were more likely to be infected with HCV. Non-IDU, recidivism, HIV infection, homelessness, mental illness, and lower education level were all significantly associated with HCV infection. The prevalence rate of HCV infection among a subset of inmates born after 1965 who denied IDU and were not infected with HIV was 5.6% (198 of 3529). Predictors of HCV infection among this group included non-IDU as well as being non-Hispanic white, Hispanic, recidivist, and homeless. Conclusion: These data reveal differences in HCV infection by sex, race/ethnicity, and socioeconomics in a large jail population, suggesting that a focused public health intervention is required and that universal screening may be warranted. Further sensitivity and cost-benefit analyses are needed to make this determination.

AB - Objective: The objective of this study was to understand predictors of hepatitis C virus (HCV) antibody positivity in a large urban jail system in New York City. Methods: We examined demographic characteristics, risk behaviors, and HCV antibody prevalence among 10 790 jail inmates aged 16 to 86 who were screened from June 13, 2013, to June 13, 2014, based on birth cohort or conventional high-risk criteria. We used logistic regression analysis to determine predictors of HCV antibody positivity. Results: Of the 10 790 inmates screened, 2221 (20.6%) were HCV antibody positive. In the multivariate analysis, HCV antibody positivity was associated most strongly with injection drug use (IDU; adjusted odds ratio [aOR] = 35.0; 95% confidence interval [CI], 28.5-43.0). Women were more likely than men to be infected with HCV (aOR = 1.3; 95% CI, 1.1-1.5). Compared with non-Hispanic black people, Hispanic (aOR = 2.1; 95% CI, 1.8-2.4) and non-Hispanic white (aOR = 1.7; 95% CI, 1.5-2.1) people were more likely to be infected with HCV. Non-IDU, recidivism, HIV infection, homelessness, mental illness, and lower education level were all significantly associated with HCV infection. The prevalence rate of HCV infection among a subset of inmates born after 1965 who denied IDU and were not infected with HIV was 5.6% (198 of 3529). Predictors of HCV infection among this group included non-IDU as well as being non-Hispanic white, Hispanic, recidivist, and homeless. Conclusion: These data reveal differences in HCV infection by sex, race/ethnicity, and socioeconomics in a large jail population, suggesting that a focused public health intervention is required and that universal screening may be warranted. Further sensitivity and cost-benefit analyses are needed to make this determination.

KW - Corrections

KW - HCV

KW - Jail

UR - http://www.scopus.com/inward/record.url?scp=85012202191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012202191&partnerID=8YFLogxK

U2 - 10.1177/0033354916679367

DO - 10.1177/0033354916679367

M3 - Article

VL - 132

SP - 41

EP - 47

JO - Public Health Reports

JF - Public Health Reports

SN - 0033-3549

IS - 1

ER -